Email ID
Password
Scrip   
VentiRx extends series A by $25 million
13 January 2010
Sukaina Virji

VentiRx Pharmaceuticals, a private US firm focused on the development of novel toll-like receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, has raised $25 million in an extension of its series A round.

The extension was led by MedImmune Ventures...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36